Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Development of 18F-labeled 2-phenylimidazo[1,2-a]pyridine analog, 18F-CB251, for TSPO-selective PET radiotracer

Byung Seok Moon, Mara Perrone, Hyun Soo Park, Valentino Laquintana, Annalisa Cutrignelli, Angela Lopedota, Massimo Franco, Nunzio Denora, Byung Chul Lee and Sang Eun Kim
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1090;
Byung Seok Moon
1Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mara Perrone
2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyun Soo Park
3Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentino Laquintana
2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annalisa Cutrignelli
2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Lopedota
2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Franco
2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nunzio Denora
2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byung Chul Lee
1Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sang Eun Kim
3Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 56 no. supplement 3 1090

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2015.

Copyright & Usage 

Author Information

  1. Byung Seok Moon1,
  2. Mara Perrone2,
  3. Hyun Soo Park3,
  4. Valentino Laquintana2,
  5. Annalisa Cutrignelli2,
  6. Angela Lopedota2,
  7. Massimo Franco2,
  8. Nunzio Denora2,
  9. Byung Chul Lee1 and
  10. Sang Eun Kim3
  1. 1Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  2. 2Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, Bari, Italy
  3. 3Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Italy

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to May 2025

AbstractFullPdf
May 2015400
Jun 20152600
Jul 2015900
Aug 2015200
Sep 2015800
Oct 2015100
Nov 2015200
Dec 2015900
Jan 2016600
Feb 2016600
Mar 2016200
Apr 2016400
May 2016500
Jun 2016600
Jul 2016200
Aug 2016100
Sep 2016400
Oct 2016300
Nov 2016200
Dec 2016100
Jan 2017700
Feb 2017100
Mar 2017600
Apr 2017700
May 2017400
Jun 2017100
Jul 2017200
Aug 2017100
Sep 2017200
Oct 2017300
Nov 2017100
Dec 2017200
Feb 2018100
Mar 2018100
May 2018100
Jun 2018200
Jul 2018300
Nov 2018100
Feb 2019200
Apr 2019200
Nov 2019500
Dec 2019200
Jan 2020100
Mar 2020200
May 2020200
Aug 2020500
Sep 2020100
Oct 2020100
Nov 2020100
Dec 2020100
Feb 2021700
Mar 2021600
Apr 2021700
May 2021400
Jun 2021200
Jul 2021600
Aug 2021400
Sep 2021400
Oct 2021300
Nov 2021100
Dec 2021400
Jan 2022400
Feb 2022400
Mar 2022200
Apr 2022600
May 2022200
Jun 2022100
Aug 2022200
Sep 2022200
Dec 2022100
Mar 2023200
Apr 2023400
May 2023200
Jun 2023100
Jul 2023100
Aug 2023300
Sep 2023500
Oct 2023200
Nov 2023400
Dec 2023300
Jan 2024700
Feb 2024100
Mar 2024300
Apr 2024400
May 2024700
Jun 2024300
Jul 2024200
Aug 20241100
Sep 2024800
Oct 2024200
Nov 2024300
Dec 2024200
Jan 2025100
Feb 2025100
Mar 2025100
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of 18F-labeled 2-phenylimidazo[1,2-a]pyridine analog, 18F-CB251, for TSPO-selective PET radiotracer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Development of 18F-labeled 2-phenylimidazo[1,2-a]pyridine analog, 18F-CB251, for TSPO-selective PET radiotracer
Byung Seok Moon, Mara Perrone, Hyun Soo Park, Valentino Laquintana, Annalisa Cutrignelli, Angela Lopedota, Massimo Franco, Nunzio Denora, Byung Chul Lee, Sang Eun Kim
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1090;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of 18F-labeled 2-phenylimidazo[1,2-a]pyridine analog, 18F-CB251, for TSPO-selective PET radiotracer
Byung Seok Moon, Mara Perrone, Hyun Soo Park, Valentino Laquintana, Annalisa Cutrignelli, Angela Lopedota, Massimo Franco, Nunzio Denora, Byung Chul Lee, Sang Eun Kim
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1090;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
  • Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Preclinical Probes for Neuroimaging Posters

  • Evaluation of Fluorinated TAZA Analogs as Potential Ligands for Aβ Plaques
  • Preliminary in vivo evaluation of a 11C-labeled tetrazine for bioorthogonal reaction within CNS
  • Development of Imaging Methods to Asses Glutamate Function at the NMDA ion channel
Show more Special MTA: Preclinical Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire